Progression to overweight, obesity and associated factors after antiretroviral therapy initiation among brazilian persons with HIV/AIDS

Nutricion Hospitalaria

Volumn 25, Issue 4, 2010, Pages 635-640

  Maia Leite, L H ^a   De Mattos Marinho Sampaio, A B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

AIDS; Body weight; HIV; Obesity; Overweight

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDY; RISK FACTOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; BRAZIL; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77954783783     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.4.4481     Document Type: Article

References (28)

1. Estrada V, Martínez-Larrad MT, González-Sánchez JL, de Villar NG, Zabena C, Fernández C et al. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy. Metabolism 2006; 55: 940-945
2. Jacobson DL, Tang AM, Spiegelman D, Thomas AM, Skinner S, Gorbach SL et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr 2006; 43: 458-466
3. Smit E. Balancing the health benefits and the risks of obesity among HIV-infected youth. J Am Diet Assoc 2004; 104: 1549-1553
4. Bouvier G. Addressing overweight and obesity in HIV-infected individuals. HIV Clin 2008; 20:10-11
5. Amorosa V Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D et al. A Table of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005; 39: 557-561
6. Hendricks KM, Willis K, Houser R, Jones CY. Obesity in HIVinfection: Dietary correlates. J Am Coll Nutr 2006; 25: 321-331
7. Jaime PC, Florindo AA, Latorre MRDO, Brasil BG, Santos ECM, Segurado AAC. Prevalěncia de sobrepeso e obesidade abdominal em indivíduos portadores de HIV/AIDS, em uso de terapia anti-retroviral de alta potěncia. Rev Bras Epidemiol 2004; 7: 65-72.
8. Fichtenbaum CJ. Metabolic Abnormalities Associated with HIV Infection and Antiretroviral Therapy. Curr Infect Dis Rep 2009; 11: 84-92.
9. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS 2008; 22: 925-930
10. AHA. American Heart Association. Diet and lifestyle recommendations revision 2006: A Scientific Statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82-96.
11. Lundgren JD, Battergay M, Behrens G, De Wit S, Guaraldi G, Katlama C et al. European AIDS Clinical Society (EACS). Guidelines on the prevention and management of metabolic diseases in HIV. HIV Medicine 2008; 9: 72-81.
12. Leite LHM, Sampaio ABMM. Metabolic abnormalities and overweight in HIV/AIDS persons treated with antiretroviral therapy. Rev Nutr 2008; 21: 277-283
13. Womack J, Tien PC, Feldman J, Shin JH, Fennie K, Anastos K et al. Obesity and immune cell counts in women. Metabolism 2007; 56: 998-1004.
14. IBGE. Instituto Brasileiro de Geografia e Estatística. Pesquisa de orçamentos familiares POF 2002-2003. Available at: http://www.ibge.gov. br (Accessed 24 March 2009).
15. Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr 2001; 26: 291-297
16. Jones CY, Hogan JW, Snyder B, Klein RS, Rompalo A, Schuman P et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV. Clin Infect Dis 2003; 37 (Supl. 2): S69-80.
17. Arendt BM, Aghdassi E, Mohammed SS, Fung LY, Jalali P, Salit IE et al. Dietary intake and physical activity in Canadian populations sample of male with HIV infection and metabolic abnormalities. Curr HIV Res 2008; 6: 82-90.
18. Salyer J, Lyon DE, Settle J, Elswick RK, Rackley D. Coronary heart disease risks and lifestyle behaviors in persons with HIV infection. J Assoc Nurses AIDS Care 2006; 17: 3-17.
19. Hendricks KM, Mwamburi DM, Newby PK, Wanke CA. Dietary patterns and health and nutrition outcomes in men living with HIV infection. Am J Clin Nutr 2008; 88: 1584-1592
20. Kruzich LA, Marquis GS, Wilson CM, Stephensen CB. HIVinfected US youth are at high risk of obesity and poor diet quality: a challenge for improving short- and long-term health outcomes. J Am Diet Assoc 2004; 104: 1554-1560
21. Jaime PC, Florindo AA, Latorre MR, Segurado AA. Central obesity and dietary intake in HIV/AIDS patients. Rev aúde Pública 2006; 40: 634-640
22. Duran ACFL, Almeida LB, Segurado AAC, Jaime PC. Diet Quality of persons living HIV/AIDS on highy active antiretroviral therapy. J Hum Nutr Diet 2008; 21: 346-350
23. Huang JS, Lee D, Becerra K, Santos R, Barber E, Mathews WC. Body image in men with HIV. AIDS Patient Care STDS 2006; 20: 668-677
24. Tate H, George R. The effect of weight loss on body image in HIV-positive gay men. AIDS Care 2001; 13: 163-169
25. Clark RA, Niccolai L, Kissinger PJ, Peterson Y, Bouvier V. Ethnic differences in body image attitudes and perceptions among women infected with human immunodeficiency virus. J Am Diet Assoc 1999; 99: 735-737
26. Reeds DN. Metabolic Syndrome risks of cardiovascular disease: differences between HIV-positive and HIV-negative? J Cardiometab Syndr 2008; 3: 79-82.
27. Calza L, Manfredi R, Pocaterra D, Chiodo F. Risk of premature atherosclerosis and ischemic heart disease associated with infection and antiretroviral therapy. J Infect 2008; 57: 16-32.
28. Blass SC, Ellinger S, Vogel M, Ingiliz P, Spengler U, Stehle P et al. Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic control. Eur J Med Res 2008; 13: 209-214